Intake of folic acid by Polish women with higher education — a survey research: can we do more?
Abstract
Objectives: The objective of the study is to determine efficacy of the Primary Prevention Program of Neural Tube Defects in Polish women with higher education in 5-year interval.
Material and methods: Survey research was conducted twice (in 2008 and 2013) in 630 female students of universities: 305 female medical students and 325 female non-medical students. The survey was also done among women aged 27– 35 who graduated from medical or non-medical universities and have at least one child. Questions concerned knowledge about prophylaxis and periconceptional folic acid intake. Chi square test was used to assess the significance.
Results: Knowledge concerning prophylaxis was significantly higher in female medical students comparing to non-medical ones, both in 2008 (p < 0,001), and in 2013 (p < 0,001). 92.9% in 2008 and 93.9% in 2013 of medical students knew about the necessity of periconceptional folic acid intake. Awareness of female non-medical students was lower (2008 — 35.3% and 2013 — 41.1%) and did not change in the 5-year long period (p = 0.3). There was no significant difference in preconceptional folic acid intake among mothers with medical and non-medical education (53.3% vs. 45% p = 0.4). However, the highest folic acid intake was among mothers –medical doctors who treat children with neural tube defect.
Conclusions: Difference between medical and non-medical students shows that better educational programs may improve knowledge about prophylaxis. Aside from knowledge, compliance with recommendations of Primary Prevention Program of Neural Tube Defects is unsatisfactory.
Keywords: transcripto
References
- Smithells RW, Nevin NC, Seller MJ, et al. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet Lond Engl. 1983; 1: 1027–1031.
- MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet. 1991; 338: 131–137.
- Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992; 327: 1832–1835.
- Berry RJ, Li Z, Erickson JD, et al. Prevention of Neural-Tube Defects with Folic Acid in China. N Engl J Med. 1999; 341: 1485–1490.
- Seremak-Mrozikiewicz A. Metafolin – alternative for folate deficiency supplementation in pregnant women. Ginekol Pol. 2013; 84: 641–646.
- Czeizel AE. Periconceptional folic acid and multivitamin supplementation for the prevention of neural tube defects and other congenital abnormalities. Birt Defects Res A Clin Mol Terato. 2009; 85: 260–268.
- Goh YI, Koren G. Folic acid in pregnancy and fetal outcomes. J Obstet Gynaecol J Inst Obstet Gynaecol. 2008; 28: 3–13.
- Yazdy MM, Honein MA, Xing J. Reduction in orofacial clefts following folic acid fortification of the U.S. grain supply. Birt Defects Res A Clin Mol Teratol. 2007; 79: 16–23.
- Fekete K, Berti C, Cetin I, et al. Perinatal folate supply: relevance in health outcome parameters. Matern Child Nutr. 2010; 6: 23–38.
- Hodgetts VA, Morris RK, Francis A, et al. Effectiveness of folic acid supplementation in pregnancy on reducing the risk of small-for-gestational age neonates: a population study, systematic review and meta-analysis. BJOG Int J Obstet Gynaeco. 2015; 122: 478–490.
- Roza SJ, van Batenburg-Eddes T, Steegers EAP, et al. Maternal folic acid supplement use in early pregnancy and child behavioural problems: The Generation R Study. Br J Nutr. 2010; 103: 445–452.
- Steenweg-de Graaff J, Roza SJ, Steegers EAp, et al. Maternal folate status in early pregnancy and child emotional and behavioral problems: the Generation R Study. Am J Clin Nutr. 2012; 95: 1413–1421.
- Goh YI, Bollano E, Einarson TR, et al. Prenatal multivitamin supplementation and rates of pediatric cancers: a meta-analysis. Clin Pharmacol Ther. 2007; 81: 685–691.
- Polish Gynecological Society Expert Group. Expert review of Polish Gynecological Society regarding micronutrient supplementation in pregnancy. Ginekol Pol. 2011; 82: 550–3.
- Der Woude PAZ, Walle HE, Berg LTv, et al. Periconceptional folic acid use: still room to improve. Birth Defects Res A Clin Mol Teratol. 2012; 94: 96–101.
- Fulford B, Macklon N, Boivin J, et al. Mental models of pregnancy may explain low adherence to folic acid supplementation guidelines: a cross-sectional international survey. Eur J Obstet Gynecol Reprod Biol. 2014; 176: 99–103.
- Bitzer J, von Stenglin A, Bannemerschult R, et al. Women's awareness and periconceptional use of folic acid: data from a large European survey. Int J Womens Health. 2013; 5: 201–213.
- Friberg AK, Jørgensen FS, Friberg AK, et al. Few Danish pregnant women follow guidelines on periconceptional use of folic acid. Dan Med J. 2015; 61.
- Cawley S, Mullaney L, McKeating A, et al. An analysis of folic acid supplementation in women presenting for antenatal care. J Public Health Oxf Engl. 2015; 38: 122–129.
- Navarrete-Muñoz EM, Giménez Monzó D, García de La Hera M, et al. Folic acid intake from diet and supplements in a population of pregnant women in Valencia, Spain. Med Clínica. 2010; 135: 637–643.
- Eurocat. Special Report 2009: Prevention of Neural Tube Defects by Periconceptional Folic Acid Supplementation in Europe. http://eurocat-network.eu/content/Special-Report-NTD-3rdEd-2009.pdf (2009).
- Eurocat. Eurocat Special Report 2013: Primary Prevention of Congenital Anomalies in European Countries. http://www.eurocat-network.eu/content/Special-Report-Primary-Preventions-of-CA.pdf (2013).
- Bagłaj M, Wojtyłko A, Bagłaj M, et al. Folic acid supplementation as prophylaxis of neural tube defect in the Lower Silesia region: fact or fiction? Med Wieku Rozwoj. 2011; 15: 5016.
- Obeid R, Pietrzik K, Oakley GP, et al. Preventable spina bifida and anencephaly in Europe. Birt Defects Res A Clin Mol Teratol. 2015; 103: 763–771.
- Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control. 1992; 41: 1–7.
- Centers for Disease Control and Prevention (CDC). Knowledge and use of folic acid by women of childbearing age--United States, 1995 and 1998. MMWR Morb Mortal Wkly Rep. 1999; 48: 325–327.
- Williams LJ, Mai CT, Edmonds LD, et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology. 2002; 66: 33–39.
- De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007; 357: 135–142.
- Ionescu-Ittu R, Marelli AJ, Mackie AS, et al. Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ. 2009; 338.
- Kim YI. Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr. 2004; 80: 1123–8.
- Kim YI. Does a high folate intake increase the risk of breast cancer? Nutr Rev. 2006; 64: 468–475.
- Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, 1998.
- Khodr ZG, Lupo PJ, Agopian AJ, et al. Preconceptional folic acid-containing supplement use in the National Birth Defects Prevention Study. Birt Defects Res A Clin Mol Teratol. 2014; 100: 472–482.
